Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT) - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Guidelines from the European Society for Blood and Marrow Transplantation (EBMT) on the Use of Defibrotide to Prevent Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in High-Risk Pediatric Patients

  • By

  • Selim Corbacioglu

  • Rajinder Bajwa

  • Ali Bülent Antmen

  • Adriana Balduzzi

  • Jaap Jan Boelens

  • Francesca Bonifazi

  • Simone Cesaro

  • Fabio Ciceri

  • Antonio Colecchia

  • Fiona Dignan

  • Katharina Kleinschmidt

  • Kris M. Mahadeo

  • Antonio Pagliuca

  • Petr Sedlacek

  • Peter J. Shaw

  • Jerry Stein

  • Zofia Szmit

  • Francesco Tambaro

  • Elif Ince

  • Marta Verna

  • Akif Yesilipek

  • Marco Zecca

  • Paul G. Richardson

  • Mohamad Mohty

  • Krzysztof Kalwak

  • January 13, 2026

Share

Original Source(s)

Related Content